Ver Publicación - Prisma - Unidad de Bibliometría

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Casali, PG ; Abecassis, N; Bauer, S; Biagini, R; Bielack, S; Bonvalot, S; Boukovinas, I; Bovee, JVMG; Brodowicz, T; Broto, JM; Buonadonna, A; Alava, E; Tos, AP; Muro, XG; Dileo, P; Eriksson, M; Fedenko, A; Ferraresi, V; Ferrari, A; Ferrari, S; Frezza, AM; Gasperoni, S; Gelderblom, H; Gil, T; Grignani, G; Gronchi, A; Haas, RL; Hannu, A; Hassan, B; Hohenberger, P; Issels, R; Joensuu, H; Jones, RL; Judson, I; Jutte, P; Kaal, S; Kasper, B; Kopeckova, K; Krakorova, DA; Cesne, A; Lugowska, I; Merimsky, O; Montemurro, M; Pantaleo, MA; Piana, R; Picci, P; Piperno-Neumann, S; Pousa, AL; Reichardt, P; Robinson, MH; Rutkowski, P; Safwat, AA; Schoffski, P; Sleijfer, S; Stacchiotti, S; Hall, KS; Unk, M; Coevorden, F; Graaf, WD; Whelan, J; Wardelmann, E; Zaikova, O; Blay, JY

Tipo: Artículo
Año de Publicación: 2018
Volumen: 29
Páginas: 68 - 78
Acceso abierto: Vía híbrida
Fuente Nº Citas Fecha Actualización
scopus32013-04-2024
wos7613-04-2024
Dimensions
PlumX
Altmetric

Año: 2018

Journal Impact Factor (JIF): 14,196

CategoríaEdiciónPosiciónCuartilTercilDecil
ONCOLOGYSCIE9/230Q1T1D1

Año: 2018

Journal Citation Indicator (JCI): 2,780

CategoríaPosiciónCuartilTercilDecilPercentil
ONCOLOGY9/302Q1T1D197,19

Año:

2018

CiteScore:

20,400

CategoríaPosiciónCuartilTercilDecil
Hematology2/122Q1T1D1
Oncology9/323Q1T1D1

SJR año:

2018

Factor de Impacto:

6,047

CategoríaPosiciónCuartilTercilDecil
Hematology3/132Q1T1D1
Medicine (miscellaneous)33/2775Q1T1D1
Oncology8/365Q1T1D1
No existen datos para la revista de esta publicación.
Agencia Código de Proyecto
Adaptaimmune-
Advenchen-
Amcure-
Amgen-
Amgen Dompe-
AROG Bayer-
AstraZeneca-
Bayer-
Blueprint Medicines-
Boehringer Ingelheim-
Bristol-Myers Squibb-
CoBioRes-
Cristal Therapeutics-
Daichii Sankyo Pharma-
Daiichi Sankyo Pharma-
Eisai-
Eli Lilly-
Epizyme-
Epizyme Inc.-
EuroSarc-
Exelixis-
Genzyme-
GlaxoSmithKline-
Incyte-
Ipsen-
Janssen-Cilag-
Lilly-
Loxo Oncology-
Medpace-
Menarini-
Merck Sharp Dohme-
Milestone-
Nanobiotix-
Nektar-
Novartis-
Novartis Oncology-
Pfizer-
PharmaMar-
PharmarMar-
Philogen-
Piqur Therapeutics-
Plexxikon-
Roche-
Sixth Element Capital-
Swedish Orphan Biovitrium-
Nota: los datos sobre financiación provienen de la WOS
# Autor Afiliación
1Casali, PG University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan (Italy)
2Abecassis, NEPE (Portugal)
3Bauer, SUniversity of Duisburg Essen (Germany)
4Biagini, RIRCCS Istituti Fisioterapici Ospitalieri (IFO) (Italy)
5Bielack, SGeneral Hospital of N. Ionia Agia Olga (Germany)
6Bonvalot, SUNICANCER (France)
7Boukovinas, INORDIX (Greece)
8Bovee, JVMGLeiden University (Netherlands)
9Brodowicz, TMedical University of Vienna (Austria)
10Broto, JMCIBER - Centro de Investigacion Biomedica en Red (Spain)
11Buonadonna, AIRCCS Aviano (CRO) (Italy)
12Alava, ECIBER - Centro de Investigacion Biomedica en Red (Spain)
13Tos, APOsped Reg Treviso S Maria Ca Foncello (Italy)
14Muro, XGCatalan Health Institute (Spain)
15Dileo, PUniversity College London Hospitals NHS Foundation Trust (England)
16Eriksson, MLund University (Sweden)
17Fedenko, AN.N. Blokhin Russian Cancer Research Center (Russia)
18Ferraresi, VInst Sci Hosp Care (Italy)
19Ferrari, AFondazione IRCCS Istituto Nazionale Tumori Milan (Italy)
20Ferrari, SIRCCS Istituto Ortopedico Rizzoli (Italy)
21Frezza, AMUniversity of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan (Italy)
22Gasperoni, SUniv Careggi Firenze (Italy)
23Gelderblom, HLeiden University (Netherlands)
24Gil, TInstitut Jules Bordet (Belgium)
25Grignani, GIRCCS Fondazione del Piemonte per l'Oncologia (Italy)
26Gronchi, AUniversity of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan (Italy)
27Haas, RLLeiden University; Netherlands Cancer Institute (Netherlands)
28Hannu, AUniversity of Turku (Finland)
29Hassan, BOxford University Hospitals NHS Foundation Trust (England)
30Hohenberger, PRuprecht Karls University Heidelberg (Germany)
31Issels, RUniversity of Munich (Germany)
32Joensuu, HUniversity of Helsinki (Finland)
33Jones, RLRoyal Marsden NHS Foundation Trust (England)
34Judson, IRoyal Marsden NHS Foundation Trust (England)
35Jutte, PUniversity of Groningen (Netherlands)
36Kaal, SRadboud University Nijmegen (Netherlands)
37Kasper, BRuprecht Karls University Heidelberg (Germany)
38Kopeckova, KMotol University Hospital (Czech Republic)
39Krakorova, DAMasaryk Memorial Cancer Institute (Czech Republic)
40Cesne, AUNICANCER (France)
41Lugowska, IMaria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology (Poland)
42Merimsky, OTel Aviv Sourasky Med Ctr Ichilov (Israel)
43Montemurro, MUniversity of Lausanne (Switzerland)
44Pantaleo, MAUniversity of Bologna (Italy)
45Piana, RA.O.U. Citta della Salute e della Scienza di Torino (Italy)
46Picci, PIRCCS Istituto Ortopedico Rizzoli (Italy)
47Piperno-Neumann, SUNICANCER (France)
48Pousa, ALHospital of Santa Creu i Sant Pau (Spain)
49Reichardt, PHelios Kliniken (Germany)
50Robinson, MHWeston Park Hospital (England)
51Rutkowski, PMaria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology (Poland)
52Safwat, AAAarhus University (Denmark)
53Schoffski, PLeuven Canc Inst (Belgium)
54Sleijfer, SErasmus University Rotterdam (Netherlands)
55Stacchiotti, SFondazione IRCCS Istituto Nazionale Tumori Milan (Italy)
56Hall, KSUniversity of Oslo (Norway)
57Unk, MInstitute of Oncology - Slovenia (Slovenia)
58Coevorden, FNetherlands Cancer Institute (Netherlands)
59Graaf, WDRoyal Marsden NHS Foundation Trust (England)
60Whelan, JUniversity of London (England)
61Wardelmann, EUniversity of Munster (Germany)
62Zaikova, OUniversity of Oslo (Norway)
63Blay, JYUniversité Claude Bernard Lyon 1; UNICANCER (France)